Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Diabetic ulcers treatment market industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Treatment type trends
2.1.4 Ulcer type trends
2.1.5 End-use trends
Chapter 3 Diabetic Ulcers Treatment Market Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of diabetes patients
3.2.1.2 Rising geriatric population
3.2.1.3 Increasing healthcare expenditure and government initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Limited awareness and late diagnosis
3.3 Growth potential analysis
3.3.1 By treatment type
3.3.2 By ulcer type
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technological landscape
3.7 Prevalence of diabetic foot ulcer, by country
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Diabetic Ulcers Treatment Market Size and Forecast, By Treatment Type (USD Million)
5.1 Key trends, by treatment type
5.2 Wound care dressings
5.2.1 Antimicrobial dressing
5.2.2 Alginate dressing
5.2.3 Hydrogel dressing
5.2.4 Foam dressing
5.2.5 Film dressing.
5.2.6 Hydrocolloid dressings
5.2.7 Other wound care dressings
5.3 Wound care devices
5.3.1 Negative pressure wound therapy
5.3.2 Hyperbaric oxygen therapy
5.3.3 Pressure relief devices
5.3.4 Electromagnetic therapy
5.3.5 Ultrasound therapy
5.4 Biologics
5.4.1 Skin grafts and substitutes
5.4.2 Growth factors
Chapter 6 Diabetic Ulcers Treatment Market Size and Forecast, By Ulcer Type (USD Million)
6.1 Key trends, by ulcer type
6.2 Foot ulcer
6.2.1 Neuro-ischemic ulcer
6.2.2 Neuropathic ulcer
6.2.3 Ischemic ulcer
6.3 Mouth ulcer
6.4 Skin ulcer
6.5 Other ulcers types
Chapter 7 Diabetic Ulcers Treatment Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Homecare settings
Chapter 8 Diabetic Ulcers Treatment Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of MEA
Chapter 9 Company Profiles
9.1 B. Braun Melsungen AG
9.2 Smith & Nephew, Inc.
9.3 Organogenesis Holdings Inc.
9.4 Derma Sciences Inc.
9.5 Integra LifeSciences
9.6 Hill Rom Holdings Inc.
9.7 Mölnlycke Health Care AB
9.8 Coloplast Corp
9.9 Cardinal Health
9.10 ConvaTec Group Plc
9.11 Tissue Regenix
9.12 3M Healthcare
9.13 Medline Industries, Inc.
